Patients

28. April 2024

DGAP-Adhoc: New Preliminary Efficacy Data for Daratumumab Presented at ASH | Dow Jones News auf 4investors.de

09.12.2012 –

DJ DGAP-Adhoc: New Preliminary Efficacy Data for Daratumumab Presented at ASH

Genmab A/S

09.12.2012 18:01

Dissemination of a Adhoc News, transmitted by DGAP – a company of
EquityStory AG.
The issuer is solely responsible for the content of this announcement.

=————————————————————————–

Company Announcement

— Preliminary Quelle: 4investors… [weiterlesen]

DRUG MARKET INFO LAUNCHES PRESENTATION READY REPORT ON CYSTIC FIBROSIS MARKET

07.12.11 | 14:20 Uhr

Drug Market Info, a new Internet source for presentation-ready market reports with the Patients? Perspective, announced today the launch of its newest research report — Cystic Fibrosis Market Info?. Cystic Fibrosis (CF) is an orphan indication that is a chronic, progressive, life-limiting autosomal recessive genetic disease that affects the lungs, digestive and reproductive systems. Quelle: ad-hoc… [weiterlesen]